BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30400091)

  • 1. Role of the Glyoxalase System in Alzheimer's Disease.
    Jiang L; Wang J; Wang Z; Huang W; Yang Y; Cai Z; Li K
    J Alzheimers Dis; 2018; 66(3):887-899. PubMed ID: 30400091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease.
    Kuhla B; Lüth HJ; Haferburg D; Boeck K; Arendt T; Münch G
    Ann N Y Acad Sci; 2005 Jun; 1043():211-6. PubMed ID: 16037241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of glyoxalase enzyme activity precludes cognitive dysfunction in a mouse model of Alzheimer's disease.
    More SS; Vartak AP; Vince R
    ACS Chem Neurosci; 2013 Feb; 4(2):330-8. PubMed ID: 23421684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Glyoxalase in Glycation and Carbonyl Stress Induced Metabolic Disorders.
    Saeed M; Kausar MA; Singh R; Siddiqui AJ; Akhter A
    Curr Protein Pept Sci; 2020; 21(9):846-859. PubMed ID: 32368974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and metabolism of methylglyoxal, S-D-lactoylglutathione and D-lactate in cancer and Alzheimer's disease. Exploring the crossroad of eternal youth and premature aging.
    de Bari L; Atlante A; Armeni T; Kalapos MP
    Ageing Res Rev; 2019 Aug; 53():100915. PubMed ID: 31173890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells.
    Kuhla B; Lüth HJ; Haferburg D; Weick M; Reichenbach A; Arendt T; Münch G
    J Neurosci Res; 2006 Jun; 83(8):1591-600. PubMed ID: 16555297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains.
    Kuhla B; Boeck K; Schmidt A; Ogunlade V; Arendt T; Münch G; Lüth HJ
    Neurobiol Aging; 2007 Jan; 28(1):29-41. PubMed ID: 16427160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer's disease?
    Krautwald M; Münch G
    Exp Gerontol; 2010 Oct; 45(10):744-51. PubMed ID: 20211718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in glyoxalase research. Glyoxalase expression in malignancy, anti-proliferative effects of methylglyoxal, glyoxalase I inhibitor diesters and S-D-lactoylglutathione, and methylglyoxal-modified protein binding and endocytosis by the advanced glycation endproduct receptor.
    Thornalley PJ
    Crit Rev Oncol Hematol; 1995 Aug; 20(1-2):99-128. PubMed ID: 7576201
    [No Abstract]   [Full Text] [Related]  

  • 10. Loss of Glyoxalase 1 Induces Compensatory Mechanism to Achieve Dicarbonyl Detoxification in Mammalian Schwann Cells.
    Morgenstern J; Fleming T; Schumacher D; Eckstein V; Freichel M; Herzig S; Nawroth P
    J Biol Chem; 2017 Feb; 292(8):3224-3238. PubMed ID: 27956549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural Glyoxalase Pathway Enhancement by Morin Derivatives in an Alzheimer's Disease Model.
    Frandsen J; Choi SR; Narayanasamy P
    ACS Chem Neurosci; 2020 Feb; 11(3):356-366. PubMed ID: 31909963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of methylglyoxal in Alzheimer's disease.
    Angeloni C; Zambonin L; Hrelia S
    Biomed Res Int; 2014; 2014():238485. PubMed ID: 24734229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylglyoxal affects cognitive behaviour and modulates RAGE and Presenilin-1 expression in hippocampus of aged mice.
    Pucci M; Aria F; Premoli M; Maccarinelli G; Mastinu A; Bonini S; Memo M; Uberti D; Abate G
    Food Chem Toxicol; 2021 Dec; 158():112608. PubMed ID: 34656697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyanidin Attenuates Methylglyoxal-Induced Oxidative Stress and Apoptosis in INS-1 Pancreatic β-Cells by Increasing Glyoxalase-1 Activity.
    Suantawee T; Thilavech T; Cheng H; Adisakwattana S
    Nutrients; 2020 May; 12(5):. PubMed ID: 32384625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics.
    Rabbani N; Xue M; Thornalley PJ
    Glycoconj J; 2016 Aug; 33(4):513-25. PubMed ID: 27406712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dicarbonyl stress in clinical obesity.
    Masania J; Malczewska-Malec M; Razny U; Goralska J; Zdzienicka A; Kiec-Wilk B; Gruca A; Stancel-Mozwillo J; Dembinska-Kiec A; Rabbani N; Thornalley PJ
    Glycoconj J; 2016 Aug; 33(4):581-9. PubMed ID: 27338619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-AGEing defences against Alzheimer's disease.
    Münch G; Kuhla B; Lüth HJ; Arendt T; Robinson SR
    Biochem Soc Trans; 2003 Dec; 31(Pt 6):1397-9. PubMed ID: 14641072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the glyoxalase pathway in human brain microvascular endothelium: effects of troglitazone and tertiary butylhydroperoxide.
    Wu L; Davies GF; Roesler WJ; Juurlink BH
    Endothelium; 2002; 9(4):273-8. PubMed ID: 12572858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.
    Takeuchi M; Yamagishi S
    Curr Pharm Des; 2008; 14(10):973-8. PubMed ID: 18473848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis.
    Shinohara M; Thornalley PJ; Giardino I; Beisswenger P; Thorpe SR; Onorato J; Brownlee M
    J Clin Invest; 1998 Mar; 101(5):1142-7. PubMed ID: 9486985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.